Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Capital Expenditures (2016 - 2025)

Utah Medical Products has reported Capital Expenditures over the past 16 years, most recently at $109000.0 for Q4 2025.

  • Quarterly results put Capital Expenditures at $109000.0 for Q4 2025, up 1111.11% from a year ago — trailing twelve months through Dec 2025 was $371000.0 (up 61.3% YoY), and the annual figure for FY2025 was $371000.0, up 61.3%.
  • Capital Expenditures for Q4 2025 was $109000.0 at Utah Medical Products, up from $27000.0 in the prior quarter.
  • Over the last five years, Capital Expenditures for UTMD hit a ceiling of $321000.0 in Q3 2022 and a floor of $9000.0 in Q4 2024.
  • Median Capital Expenditures over the past 5 years was $99500.0 (2023), compared with a mean of $130050.0.
  • Biggest five-year swings in Capital Expenditures: tumbled 97.8% in 2021 and later surged 2270.0% in 2022.
  • Utah Medical Products' Capital Expenditures stood at $253000.0 in 2021, then tumbled by 84.98% to $38000.0 in 2022, then skyrocketed by 136.84% to $90000.0 in 2023, then plummeted by 90.0% to $9000.0 in 2024, then soared by 1111.11% to $109000.0 in 2025.
  • The last three reported values for Capital Expenditures were $109000.0 (Q4 2025), $27000.0 (Q3 2025), and $51000.0 (Q2 2025) per Business Quant data.